Concepedia

Sinja Taavitsainen

ST

17

Publications

1.8K

Citations

15

H-Index

2018

Active since

Affiliations

Tampere University(Current)

University of British Columbia

Tampere University Hospital

BC Cancer Agency

Sinja Taavitsainen is an author at Tampere University specializing in urology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2018–2024

17

Publications

17

Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer

Matti Annala, Gillian Vandekerkhove, Daniel Khalaf et al. · Cancer Discovery · 2018 · 507 citations · Full text

, , +17

Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial

Daniel Khalaf, Matti Annala, Sinja Taavitsainen et al. · The Lancet Oncology · 2019 · 338 citations

, , +8

Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer

Gillian Vandekerkhove, Jean‐Michel Lavoie, Matti Annala et al. · Nature Communications · 2021 · 151 citations · Full text

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse

Sinja Taavitsainen, Nikolai Engedal, Shaolong Cao et al. · Nature Communications · 2021 · 109 citations · Full text

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer

Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts et al. · Nature Communications · 2024 · 101 citations · Full text

Rows per page

1–5 of 17